Effect of Intra-session Exercise Modes Sequence on Ventricular Function in Patients With Chronic Heart Failure
NCT ID: NCT06626542
Last Updated: 2026-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2023-09-03
2025-08-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness of Low -Versus High -Volume High -Intensity Interval Training in Patients With Chronic Heart Failure
NCT07325942
Effect of Aquatic High Intensity Resistive Training on Patients With Chronic Heart Failure
NCT06297707
Clinical Relevance of Different Training Intensities in Chronic Heart Failure.
NCT05213546
Eccentric Resistance Training Among Individuals With Chronic Heart Failure
NCT06032780
CWT Versus AT on Selected Cardiovascular Indices and Functional Capacity in Patients With Ischemic Cardiomyopathy.
NCT05674955
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Study group (A) includes 20 patients who will receive intra-session exercise modes sequence of aerobic cardiovascular training (CVT) then resistance training (RT) exercises in addition to routine treatment programme.
2. Study group (B) includes 20 patients who will receive intra-session exercise modes sequence of resistance training (RT) then aerobic cardiovascular training (CVT) exercises in addition to routine treatment programme.
3. Control group (C) includes 20 patients who will receive routine treatment programme only.
The exercise training programme for both study groups A and B will be applied once per day, three times per week for 12 consecutive weeks.
Inclusion criteria:
All participated patients will be:
* Male patients with chronic heart failure and ages from 55 to 65 years old.
* Class II and class III heart failure according to NYHA classification.
* HFrEF category with LVEF \<40% as documented by echocardiogram within \<6 months.
* Receiving the same medical treatment programme for at least 3 months.
* Having a close level of functional capacity assessed by 6 minute walking test.
Exclusion criteria:
Patients who meet one of the following criteria will be excluded:
* Uncontrolled atrial fibrillation.
* Diabetes mellitus.
* Myocardial infarction or recurrent angina within \<3 months.
* Patients with chronic chest diseases.
* Severe stenotic valvular disease.
* Clinically significant peripheral vascular disease.
* Exercise-induced angina, ST segment changes or exercise induce AV block.
* Patients with chronic renal failure.
* Any cognitive impairment that interferes with prescribed exercise procedures.
* Musculoskeletal or neurological limitation to physical exercise.
RESEARCH ETHICS
The protocol of this study will be approved by the ethics committee of scientific research at the Faculty of Physical Therapy, Cairo University. The study procedure will be explained in details for every patient before the initial assessment. All patients will be informed about the purpose, nature, and potential risks of the study, and a written informed consent will be obtained before participation in the study. The participants' right confidentiality will be observed strictly.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sequence of aerobic cardiovascular training (CVT) then resistance training (RT) exercises
resistance and aerobic training exercises
resistance and aerobic training exercises
sequence of resistance training (RT) then aerobic cardiovascular training (CVT) exercises
resistance and aerobic training exercises
resistance and aerobic training exercises
control group routine treatment programme only
resistance and aerobic training exercises
resistance and aerobic training exercises
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
resistance and aerobic training exercises
resistance and aerobic training exercises
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Class II and class III heart failure according to NYHA classification.
* HFrEF category with LVEF \<40% as documented by echocardiogram within \<6 months.
* Receiving the same medical treatment programme for at least 3 months.
* Having a close level of functional capacity assessed by 6 minute walking test
Exclusion Criteria
* Diabetes mellitus.
* Myocardial infarction or recurrent angina within \<3 months.
* Patients with chronic chest diseases.
* Severe stenotic valvular disease.
* Clinically significant peripheral vascular disease.
* Exercise-induced angina, ST segment changes or exercise induce AV block.
* Patients with chronic renal failure.
* Any cognitive impairment that interferes with prescribed exercise procedures.
* Musculoskeletal or neurological limitation to physical exercise.
55 Years
65 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yasser Mostafa Mohamed Elhamamsy
Yasser Mostafa Mohamed El-hamamsy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Heart Institute
Giza, Agouza Giza Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/004786
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.